|
ES2281977T3
(es)
|
1998-12-22 |
2007-10-01 |
Microscience Limited |
Proteinas de estreptococo del grupo b y su utilizacion.
|
|
US6890539B2
(en)
|
1998-12-22 |
2005-05-10 |
Microscience, Ltd. |
Genes and proteins, and their use
|
|
US7939087B2
(en)
|
2000-10-27 |
2011-05-10 |
Novartis Vaccines And Diagnostics, Inc. |
Nucleic acids and proteins from Streptococcus groups A & B
|
|
US7709009B2
(en)
|
2003-07-31 |
2010-05-04 |
Novartis Vaccines And Diagnostics, Srl |
Immunogenic compositions for streptococcus pyogenes
|
|
US8945589B2
(en)
|
2003-09-15 |
2015-02-03 |
Novartis Vaccines And Diagnostics, Srl |
Immunogenic compositions for Streptococcus agalactiae
|
|
EP1807446A2
(en)
*
|
2004-10-08 |
2007-07-18 |
Novartis Vaccines and Diagnostics, Inc. |
Immunogenic and therapeutic compositions for streptococcus pyogenes
|
|
EP1801235A1
(en)
|
2005-12-20 |
2007-06-27 |
Institut Pasteur |
Rapid detection of the "high virulent" ST-17 clone of Group B streptococcus
|
|
CA2654968A1
(en)
*
|
2006-06-19 |
2008-02-21 |
Mutabilis |
Identification of genes implicated in the virulence of streptococcus agalactiae
|
|
US20100150943A1
(en)
*
|
2006-07-26 |
2010-06-17 |
Novartis Ag |
Immunogenic compositions for gram positive bacteria
|
|
US8287885B2
(en)
|
2007-09-12 |
2012-10-16 |
Novartis Ag |
GAS57 mutant antigens and GAS57 antibodies
|
|
EP2135877A1
(en)
*
|
2008-06-19 |
2009-12-23 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Marker of steptococcus anginosus/Streptococcus constellatus (Moac) and uses thereof
|
|
US8147849B2
(en)
|
2009-02-20 |
2012-04-03 |
Novartis Ag |
Protective antigens for group B Streptococcus hypervirulent strains
|
|
ITMI20090946A1
(it)
|
2009-05-28 |
2010-11-29 |
Novartis Ag |
Espressione di proteine ricombinanti
|
|
JP5931724B2
(ja)
|
2009-06-29 |
2016-06-08 |
ジェノセア バイオサイエンシーズ， インコーポレイテッド |
ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｎｅｕｍｏｎｉａｅに対するワクチンおよび組成物
|
|
GB201101665D0
(en)
|
2011-01-31 |
2011-03-16 |
Novartis Ag |
Immunogenic compositions
|
|
SG10201600435UA
(en)
|
2011-01-20 |
2016-02-26 |
Genocea Biosciences Inc |
Vaccines And Compositions Against Streptococcus Pneumoniae
|
|
KR20140026372A
(ko)
*
|
2011-02-02 |
2014-03-05 |
이무노퓨처 아이앤씨. |
혈액-뇌 장벽을 투과하는 약물 전달체, 펩티드 및 이의 용도
|
|
EP2557424A1
(en)
*
|
2011-08-11 |
2013-02-13 |
InGen Biosciences |
Method for diagnosing Streptococcus, Enterococcus and Pepstostreptococcus genera infections
|
|
CN104321335A
(zh)
*
|
2012-02-24 |
2015-01-28 |
诺华股份有限公司 |
菌毛蛋白质和组合物
|
|
CN104334736A
(zh)
*
|
2012-03-30 |
2015-02-04 |
纳幕尔杜邦公司 |
对于过酸的生产有用的酶
|
|
CN104582718B
(zh)
|
2012-10-03 |
2017-10-24 |
诺华股份有限公司 |
免疫原性组合物
|
|
EP3021864A1
(en)
*
|
2013-07-16 |
2016-05-25 |
Université de Lausanne |
Bacterial lysins and uses thereof
|
|
BR112017002183A2
(pt)
*
|
2014-08-05 |
2018-01-16 |
Glaxosmithkline Biologicals S.A. |
conjugado, composição farmacêutica, e, método para aumentar uma resposta imune em um mamífero
|
|
AU2017214441B2
(en)
|
2016-02-04 |
2021-08-19 |
Genovis Ab |
New Streptococcal proteases
|
|
WO2018204153A1
(en)
*
|
2017-05-02 |
2018-11-08 |
Venomyx, Inc. |
Composition and methods for treating snake envenomation
|
|
WO2018237010A2
(en)
*
|
2017-06-20 |
2018-12-27 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Vaccine compositions and methods of using the same
|
|
PL239045B1
(pl)
*
|
2018-01-09 |
2021-11-02 |
Inst Immunologii I Terapii Doswiadczalnej Polskiej Akademii Nauk |
Epitop specyficzny dla zakaźnych Streptococcus agalactiae oraz sposób wykrywania zakażenia pacjenta szczepem Streptococcus agalactiae
|
|
GB2590210B
(en)
*
|
2018-06-13 |
2023-01-25 |
Gen Probe Inc |
Compositions and methods for detecting group B Streptococcus nucleic acid
|
|
KR20210055694A
(ko)
|
2018-08-06 |
2021-05-17 |
메디카인 인코포레이티드 |
Il-2 수용체 결합 화합물
|
|
MX2022005411A
(es)
|
2019-11-05 |
2022-08-10 |
Medikine Inc |
COMPUESTOS DE UNIÓN A IL-2RßYC.
|
|
AU2020395148A1
(en)
*
|
2019-12-06 |
2022-06-23 |
Theratechnologies Inc. |
Sortilin binding conjugate compounds, compositions and uses thereof for treating cancer
|
|
US11746139B2
(en)
|
2020-02-03 |
2023-09-05 |
Medikine, Inc. |
IL-7Rαγc binding compounds
|
|
AU2021219847A1
(en)
*
|
2020-02-12 |
2022-10-13 |
Massachusetts Institute Of Technology |
Field deployable CRISPR-Cas diagnostics and methods of use thereof
|
|
US11453907B2
(en)
|
2020-03-23 |
2022-09-27 |
The Broad Institute, Inc. |
Crispr effector system based coronavirus diagnostics
|
|
WO2022026534A1
(en)
*
|
2020-07-28 |
2022-02-03 |
Kansas State University Research Foundation |
Sars-cov-2 immunogenic compositions and methods for protecting against sars-cov-2 clinical signs
|
|
EP4240394A4
(en)
*
|
2020-11-04 |
2024-10-23 |
Medikine, Inc. |
IL-2R BETA-GAMMA C-BINDING COMPOUNDS AND USES THEREOF
|
|
US11999771B2
(en)
|
2022-04-07 |
2024-06-04 |
Medikine, Inc. |
IL-7Rαγc ligand immunoglobulin fusion proteins
|
|
JP2026525956A
(ja)
*
|
2023-07-18 |
2026-08-04 |
インターベット インターナショナル ベー． フェー． |
新規型のストレプトコッカス・アガラクティエ血清型ｉａ細菌およびそのワクチン
|
|
TW202542195A
(zh)
*
|
2024-01-08 |
2025-11-01 |
美商得納利醫療公司 |
用於調節Ｔａｕ表現之組成物及方法
|
|
WO2025250877A1
(en)
*
|
2024-05-31 |
2025-12-04 |
Saliogen Therapeutics, Inc. |
Mobile genetic elements from myotis myotis
|